Continuous use without cycling, IGF-1 monitoring, and dose review is not appropriate practice
The assessment week exists for a reason
Establishing a consistent injection schedule : Choose a specific day and approximate time each week for your injection
These discrepancies might be attributed to several factors, including differences in blood sample sources, medication status, disease state, sample processing methods, sample size, and the heterogeneity of OS responses across different stages of schizophrenia
Wegovy (semaglutide) Disease area(s): Metabolic diseases Manufacturer(s): Novo Nordisk 2024 Sales (USD): $8.44 billion Why it sold so well: In 2024, Novo Nordisks obesity products, including Wegovy and Saxenda, achieved significant sales growth, increasing by 56% in Danish kroner to DKK 58.21 billion ($8.44 billion USD)